Showing results (21-30 of 76) with videos related to
Sort By:
Pageof 8
Cancer Immunology Research|April 30, 2014
Combining oncolytic HSV-1 with immunogenic cell death-inducing drug mitoxantrone breaks cancer immune tolerance and improves therapeutic efficacySamuel T Workenhe, Jonathan G Pol, Brian D Lichty, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2007
Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunizationMichael Santosuosso, Sarah McCormick, Elizabeth Roediger, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 24, 2009
Intelligent design: combination therapy with oncolytic virusesKathryn Ottolino-Perry, Jean-Simon Diallo, Brian D Lichty, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 2, 2010
Adaptive antiviral immunity is a determinant of the therapeutic success of oncolytic virotherapyPaul T Sobol, Jeanette E Boudreau, Kyle Stephenson, et al.Oncoimmunology|March 1, 2021
Synergistic anti-tumor efficacy of oncolytic influenza viruses and B7-H3 immune- checkpoint inhibitors against IC-resistant lung cancersDörthe Masemann, Ramona Meissner, Tanja Schied, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2008
A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replicationRobert E Edge, Theresa J Falls, Christopher W Brown, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 19, 2010
Immunotherapy can reject intracranial tumor cells without damaging the brain despite sharing the target antigenByram W Bridle, Jian Li, Shucui Jiang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 18, 2013
Immunogenic HSV-mediated oncolysis shapes the antitumor immune response and contributes to therapeutic efficacySamuel T Workenhe, Graydon Simmons, Jonathan G Pol, et al.Human Gene Therapy|September 9, 2004
Vesicular stomatitis virus: a potential therapeutic virus for the treatment of hematologic malignancyBrian D Lichty, David F Stojdl, Rebecca A Taylor, et al.Journal of Virology|October 31, 2008
The p14 FAST protein of reptilian reovirus increases vesicular stomatitis virus neuropathogenesisChristopher W Brown, Kyle B Stephenson, Stephen Hanson, et al.Pageof 8